Paclitaxel and carboplatin chemotherapy in patients with metaststic melanoma refractory to BRAF/MEK inhibitors.

被引：0
|
作者：
Samoylenko, Igor
Kharkevich, Galina
Petenko, Natalia N.
Orlova, Kristina V.
Sinelnikov, Igor
Utyashev, Igor A.
Vikhrova, Anastasia
Markina, Irina
Demidov, Lev V.
机构：
[1] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
[2] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.9552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9552
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Chemotherapy in patients with metaststic melanoma after progression on BRAF/MEK inhibitors
    Samoylenko, I. V.
    Kharkevich, G.
    Demidov, L. V.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] BRAF and MEK inhibitors in BRAF-mutant melanoma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [3] Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors
    Carbonnel, Franck
    Routier, Emilie
    Lazure, Thierry
    Mussini, Charlotte
    Bellanger, Christophe
    Merklen, Carine
    Bejou, Bakhtiar
    Buisson, Anthony
    Amiot, Aurelien
    Meyer, Antoine
    Dong, Catherine
    Robert, Caroline
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (07) : 792 - 799
  • [4] Resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Yacoub, Nour
    Garrett, Joan T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB43 - AB43
  • [5] BRAF and MEK inhibitors in therapy of advanced melanoma
    Kosela, Hanna
    Switaj, Tomasz
    Rutkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (05): : 246 - 253
  • [6] Combination of regorafenib with BRAF-/MEK-inhibitors for the treatment of patients with refractory melanoma brain metastases.
    Dirven, Iris
    Vander Mijnsbrugge, An-Sofie
    Vounckx, Manon
    Tijtgat, Jens
    Wilgenhof, Sofie
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma
    Cybulska-Stopa, Bozena
    Rogala, Pawel
    Czarnecka, Anna M.
    Galus, Lukasz
    Dziura, Robert
    Rajczykowski, Marcin
    Kubiatowski, Tomasz
    Wisniewska, Magdalena
    Gega-Czarnota, Adrianna
    Teterycz, Pawel
    Ziobro, Marek
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    MELANOMA RESEARCH, 2020, 30 (05) : 465 - 471
  • [8] Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma
    Sada, Ikuyo
    Harada, Yosuke
    Hiyama, Tomona
    Mizukami, Mina
    Kan, Takanobu
    Kawai, Mikio
    Kiuchi, Yoshiaki
    MELANOMA RESEARCH, 2023, 33 (06) : 539 - 546
  • [9] Combination chemotherapy of carboplatin and paclitaxel for metastatic melanoma
    Sato, Yuki
    Uhara, Hisashi
    Ashida, Atsuko
    Okuyama, Ryuhei
    JOURNAL OF DERMATOLOGY, 2013, 40 (12): : 1050 - 1051
  • [10] Management of toxicities of BRAF inhibitors and MEK inhibitors in advanced melanoma
    Sibaud, Vincent
    Baric, Lilian
    Cantagrel, Alain
    Di Palma, Mario
    Ederhy, Stephane
    Paques, Michel
    Perlemuter, Gabriel
    BULLETIN DU CANCER, 2021, 108 (05) : 528 - 543
12345